FMSG: Bio: Biophysical Modulation for Scalable Biomanufacturing of Stem Cell-Derived Therapeutics
FMSG: Bio: Biophysical Modulation for Scalable Biomanufacturing of Stem Cell-Derived Therapeutics
批准号:
2134494
负责人:
Rebekah Samsonraj
金额:
$46.63万
依托单位:
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-01-01 至 2024-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Extracellular vesicles (EVs) derived from mesenchymal stem cells (MSCs) are promising therapeutic agents for a range of clinical disorders owing to their immunomodulatory and pro-regenerative functions. A major bottleneck in EV biomanufacturing is scalability during development of a product to achieve clinically relevant doses. Current practices rely on invasive manipulations of cells and culture conditions, which can have deleterious implications on the final product and can incur high cost and operate at small scales, making them less viable for best-practice manufacturing. This project will improve EV production through noninvasive mechanical stimulation of MSCs by delivering low magnitude mechanical signals to MSCs cultured in two-dimensional and three-dimensional systems. This project will identify cellular responses to biophysical modulations and evaluate improvements to overall secretome, EV production, and functionality. The project will not only add new fundamental knowledge on mechanotransduction in MSCs behind EV release, but also provide functional evidence for overcoming large-scale manufacturing challenges in EV production. Students from underrepresented populations will engage in research; this will help train and develop a strong and diverse future biomanufacturing workforce, together having wide-reaching impacts on education, science and engineering, and the U.S economy. This Future Manufacturing award is supported by the following Division/Programs and Offices: ENG/CBET, MPS/CHE, MPS/DMR, EHR/DUE, and OIA/EPSCoR.Strategies to improve EV production include hypoxic culture conditions, serum starvation, and immortalization of MSCs – all of which have deleterious implications in cell integrity and functionality and operate at small scales, thus necessitating development of feasible methods to enhance manufacturing. This project is based on the scientific premise that MSCs are mechanosensitive cells responding to mechanical stimuli. The central hypothesis is that delivery of mechanical cues/forces in the form of low-magnitude mechanical stimulation (LMMS) to MSCs can affect (i) cell membrane integrin-cytoskeletal interactions that regulate actin dynamics and vesicle transport, and (ii) alter intracellular calcium levels leading to consequential release of EVs. The project harnesses the mechanotransduction of external forces on actin via integrins/talin, and subsequent influence on EV machinery towards the overall improvement in EV secretion by MSCs. Based on preliminary evidence that mechanical signals increase overall MSC secretome and EV concentration, this Future Manufacturing project will investigate the mechanisms behind mechanically triggered EV release, and will determine qualitative and functional improvements in EVs secreted in response to mechanical stimulation. The project will establish a minimally manipulative biophysical method to scale-up manufacturing of EVs from MSCs through delivery of low magnitude mechanical vibrations. The three major objectives are (1) To evaluate the effects of LMMS-based biophysical cell modulation system on EV release and unravel underlying mechanotransduction changes in MSCs in response to LMMS; (2) To assess functional potency of LMMS-induced EVs for immunosuppression (in vitro) and tissue regeneration (in vivo) in a critical-sized calvarial defect model; and (3) Leverage research outcomes to support education and development of a skilled technical workforce in the state of Arkansas by engaging undergraduate, graduate, and middle school students in biomanufacturing education and research. The project will benefit the field of life sciences, manufacturing and bioengineering education and research, contributing to sustained U.S. competitiveness in EV biomanufacturing for research and therapy.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.biochi.2022.11.011
发表时间:
2022-12-02
期刊:
BIOCHIMIE
影响因子:
3.9
作者:
[Williams, Taylor, Salmanian, Ghazaleh, Samsonraj, Rebekah Margaret]
通讯作者:
Samsonraj, Rebekah Margaret
国内基金
海外基金
登录
查看更多内容
NGQDs/BiO2-x/PANI新型复合光催化剂的构筑及其可见光催化还原Cr(VI)的性能与机制研究
-
批准号:2026JJ80226
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:唐新德
-
依托单位:
骨胶原(Bio-Oss Collagen)联合龈下喷砂+骨皮质切开术治疗
根分叉病变的临床疗效研究
-
批准号:2024JJ9542
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:潘涛华
-
依托单位:
基于通用型 M13-Bio 噬菌体信号放大的动态
光散射免疫传感检测平台的建立及机制研究
-
批准号:Q24C200014
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:湛胜楠
-
依托单位:
智能双栅调控InSe Bio-FET可控构筑与原位细胞传感机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
2D/2D BiO2-x/graphyne异质结光热活化过硫酸盐降解水体中抗生素的机理研究
-
批准号:LY23E080003
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:李必胜
-
依托单位:
过渡金属掺杂与原位外延生长Z型异质结协同增强BiO2-x的宽光谱光催化活化分子氧去除水中难降解微塑料的机理研究
-
批准号:--
-
项目类别:--
-
资助金额:60万元
-
批准年份:2021
-
负责人:张高科
-
依托单位:
BIO促进脂肪来源干细胞修复急性心肌梗死的作用及机制
-
批准号:32071365
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:杨向群
-
依托单位:
Z型异质结“(金属氧化物MOx@薄层碳TC)/BiO1-xCl”的可控构筑及其光催化性能的研究
-
批准号:22005126
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:孙立鸣
-
依托单位:
6-BIO 抗肝脏衰老的作用与作用机制研究
-
批准号:19ZR1438800
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2019
-
负责人:苗雅
-
依托单位:
基于MOFs热解构建薄层碳包覆的BiO1-xX基Z型异质结及其光催化水氧化苯制苯酚反应的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2019
-
负责人:
-
依托单位: